首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

2138155

智慧藥丸及攝取感測器市場：預測（至2034年）－按產品類型、感測器類型、目標疾病、應用、最終使用者和地區分類的全球分析

Smart Pills & Ingestible Sensors Market Forecasts to 2034 - Global Analysis By Product Type (Smart Pills and Ingestible Sensors), Sensor Type, Targeted Disease, Application, End User and By Geography

出版日期: 2026年09月30日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球智慧藥丸和攝取感測器市場預計將在 2026 年達到 74 億美元，並在預測期內以 9.5% 的複合年成長率成長，到 2034 年達到 154 億美元。

智慧藥丸和吸入式感測器是新興的醫療技術，它們可在服用後實現體內監測、診斷評估和控制治療。這些微型設備可能包含小型攝影機、感測器、通訊組件或治療系統，並在消化器官系統內運作。它們的應用包括測量生理狀態、驗證用藥依從性、識別胃腸道問題以及收集診斷信息，而無需使用傳統的侵入性方法。個人化醫療、遠端患者監護和微創醫療的日益普及正在推動設備小型化、無線通訊、感測器功能和生物相容性設計方面的進步。

據美國國立衛生研究院 (NIH) 稱，研究人員開發了一種可攝入式感測器設備，在測試中，該設備能夠承受胃部環境長達 29 天，每 10 分鐘收集一次溫度數據，這表明口服型感測器在長期健康監測方面具有潛力。

遠端患者監護的需求日益成長

遠端患者監護的日益普及正在加速智慧藥丸和口腔感測器市場的成長。智慧藥丸和口腔感測器能夠為醫療專業人員提供生理資訊和用藥依從性分析，同時減少患者反覆就診的次數。這些設備可以傳輸用藥依從性、消化功能和整體健康狀況等訊息，從而實現對患者的持續評估。這些功能有助於及時做出臨床決策，並及早發現潛在的健康問題。隨著互聯醫療、居家醫療和數位化監護的擴展，人們對將口服型技術整合到現代病患照護系統中的興趣日益濃厚。

高昂的研發和製造成本

智慧藥丸和吸入式感測器市場面臨高昂的研發和製造成本限制。口服型裝置依賴小型感測器、先進的電子元件、生物相容性材料、通訊系統以及嚴格的測試，以確保其在體內安全運作。將多種功能整合到可吞嚥裝置中也帶來了技術和製造方面的挑戰，從而推高了成本。此外，臨床試驗、法規核准、品質要求和特殊的製造流程也增加了經濟負擔。這些成本可能會限制中小型製造商進入市場，並延緩成本敏感型醫療機構的採用。

個人化醫療和精準醫療的擴展

個人化和精準醫療的日益普及為智慧藥丸和吸入式感測器市場帶來了巨大的機會。智慧藥丸可以收集個別生理數據，從而深入了解消化系統健康狀況、藥物療效和用藥依從性。這些資訊有助於臨床醫生製定更個人化的診斷、監測和治療方案。隨著個人化醫療保健策略日益重要，對這些技術的需求也不斷成長。與數位醫療平台和電子醫療系統的整合將拓展其在個人化護理、持續監測和臨床決策方面的應用範圍。

資料隱私與網路安全風險

網路安全和病患資料保護問題對智慧藥丸和口腔感測器市場構成重大威脅。口腔設備可能會收集敏感的健康和用藥訊息，然後透過連接的數位系統傳輸這些資訊。安全漏洞、未授權存取或資料外洩可能導致敏感資訊外洩或損害病患信任。製造商和醫療機構可能需要在加密、身份驗證和安全資料管理方面投入巨資。更嚴格的隱私法規和不斷提高的網路安全期望可能會推高技術成本，同時進一步阻礙其廣泛應用。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對智慧藥丸和吸入式感測器市場產生了複雜的影響，波及醫療服務、研發活動、生產和供應鏈網路。醫院就診次數減少和限制人際接觸的措施加速了遠距監測和數位化醫療解決方案的普及。另一方面，診斷延遲、臨床研究延遲、生產中斷和零件短缺暫時阻礙了產品的研發和商業化。疫情期間遠距遠端醫療的興起，隨後提升了人們對微創監測的興趣，刺激了對智慧口腔設備的投資，並促進了其在醫療機構的更廣泛應用。

在預測期內，智慧藥丸細分市場預計將佔據最大的市場佔有率。

由於智慧藥丸能夠將診斷、監測和治療功能整合到可吞嚥的醫療設備中，預計在預測期內，智慧藥丸細分市場將佔據最大的市場佔有率。這些智慧藥丸可能包含微型攝影機、感測器、通訊組件和藥物傳輸系統，用於收集胃腸道內的資訊。其應用包括追蹤用藥依從性、檢查胃腸道狀況、支持標靶治療以及評估生理功能。能夠在最大限度減少患者不適的同時獲取體內健康信息，提升了其醫療價值。微型電子、無線通訊和生物相容性材料的不斷進步正在拓展其臨床應用。

在預測期內，居家醫療領域預計將呈現最高的複合年成長率。

在預測期內，居家醫療領域預計將呈現最高的成長率，這主要得益於智慧藥丸和口腔感測器能夠在住宅環境中實現監測和診斷。這些設備可以幫助患者堅持服藥、收集生理資訊並進行遠距患者評估，從而減少患者重複前往醫療機構就診的次數。人們對便利性和個人化照護日益成長的需求正在推動家庭互聯醫療保健技術的應用。此外，與遠端醫療服務和遠距監測平台的整合也提升了口服型技術在居家照護、持續監測和長期健康管理中的重要性。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的醫療保健體系、對先進醫療技術的高度接受度以及成熟的數位化醫療環境。互聯醫療設備、微創診斷和遠端患者監護在該地區已廣泛應用。強大的醫療服務提供者、研究機構和科技公司網路也為市場發展做出了貢獻。數位化醫療的進步和對個人化醫療日益成長的重視，進一步推動了智慧藥丸和口腔感測器技術在臨床環境中的應用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於創新醫療監測和診斷解決方案的日益普及。該地區醫療基礎設施的改善、醫療技術認知度的提高以及對微創手術的偏好不斷增強，都在推動這些解決方案的普及。醫療數位化和遠端監測實踐的擴展，進一步提升了口服型設備的市場機會。此外，研發能力的提升、技術的進步以及對醫療保健領域投資的增加，也推動了智慧藥丸和口服感測器在新興醫療應用中的進一步整合。

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

公司簡介
- 對其他公司（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域分類
- 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

產業加值網路與供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

企業合併（M&A）
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Medtronic
Olympus Corporation
CapsoVision, Inc.
IntroMedic Co., Ltd.
Check-Cap Ltd.
ANX Robotica
BodyCap
etectRx
Otsuka Holdings
Proteus Digital Health
JINSHAN Science & Technology（Group）Co., Ltd.
RF Co., Ltd.
Koninklijke Philips NV
Biora Therapeutics, Inc.
Rani Therapeutics
Veloce Corporation
Endiatx
Fujifilm Holdings Corporation

簡介目錄圖表

Product Code: SMRC39741

According to Stratistics MRC, the Global Smart Pills & Ingestible Sensors Market is accounted for $7.4 billion in 2026 and is expected to reach $15.4 billion by 2034 growing at a CAGR of 9.5% during the forecast period. Smart pills and ingestible sensors represent emerging healthcare technologies that enable internal monitoring, diagnostic assessment, and controlled treatment delivery after being swallowed. These compact devices may contain miniature cameras, sensors, communication components, or therapeutic systems that operate within the digestive system. Their applications include measuring physiological conditions, confirming medication adherence, identifying gastrointestinal issues, and gathering diagnostic information without conventional invasive techniques. Increasing adoption of personalized medicine, remote patient monitoring, and minimally invasive healthcare is driving advances in device miniaturization, wireless communication, sensor capabilities, and biocompatible designs.

According to NIH, researchers developed a swallowable sensor device that survived stomach conditions for up to 29 days in testing and collected temperature data every 10 minutes, demonstrating the potential of ingestible sensors for long-duration health monitoring.

Market Dynamics:

Driver:

Growing demand for remote patient monitoring

The rising adoption of remote patient monitoring is accelerating the Smart Pills & Ingestible Sensors Market. Smart pills and ingestible sensors provide healthcare professionals with physiological and medication-related insights while reducing dependence on repeated clinical visits. These devices can communicate information concerning adherence, digestive functions, and internal health conditions, enabling ongoing patient assessment. Such capabilities support timely clinical decisions and earlier detection of potential health issues. Expansion of connected healthcare, home healthcare, and digital monitoring is consequently increasing interest in integrating ingestible technologies into modern patient-care systems.

Restraint:

High development and manufacturing costs

The Smart Pills & Ingestible Sensors Market faces limitations from substantial development and production expenses. Ingestible devices depend on compact sensors, advanced electronic components, biocompatible materials, connectivity systems, and extensive testing for safe internal operation. Combining several capabilities within a swallowable device also creates technical and manufacturing challenges that can raise costs. Furthermore, clinical studies, regulatory approvals, quality requirements, and specialized production processes add financial burdens. Such expenses may restrict participation by smaller manufacturers and slow adoption among cost-sensitive healthcare organizations.

Opportunity:

Expansion of personalized and precision healthcare

Growing adoption of personalized and precision medicine offers considerable opportunities for the Smart Pills & Ingestible Sensors Market. Smart pills can gather individual physiological data and generate insights related to digestive health, medication effectiveness, and adherence patterns. This information can help clinicians develop more customized approaches to diagnosis, monitoring, and treatment. The increasing emphasis on patient-specific healthcare strategies is creating demand for these technologies. Connectivity with digital healthcare platforms and electronic medical systems can also broaden applications in individualized care, continuous monitoring, and clinical decision-making.

Threat:

Data privacy and cybersecurity risks

Cybersecurity and patient data protection concerns represent a major threat to the Smart Pills & Ingestible Sensors Market. Ingestible devices may gather confidential health and medication information before transmitting it through connected digital systems. Security vulnerabilities, unauthorized access, or data breaches could expose sensitive information and undermine patient confidence. Manufacturers and healthcare organizations may need to invest more heavily in encryption, authentication, and secure data management. Increasing privacy regulations and cybersecurity expectations could raise technology costs while creating additional barriers to broader adoption.

Covid-19 Impact:

COVID-19 had a mixed impact on the Smart Pills & Ingestible Sensors Market, influencing healthcare delivery, research activities, production, and supply networks. Reduced hospital visits and efforts to limit physical contact encouraged greater adoption of remote monitoring and digital care solutions. Conversely, postponed diagnostics, clinical research delays, production disruptions, and shortages of components created temporary obstacles for development and commercialization. The shift toward remote healthcare during the pandemic subsequently strengthened interest in minimally invasive monitoring, encouraging investment in connected ingestible devices and supporting their broader healthcare adoption.

The smart pills segment is expected to be the largest during the forecast period

The smart pills segment is expected to account for the largest market share during the forecast period due to their ability to integrate diagnostic, monitoring, and treatment functions into swallowable medical devices. They may contain compact cameras, sensors, communication components, and medication delivery systems that gather information within the gastrointestinal tract. Applications include tracking medication adherence, examining gastrointestinal conditions, supporting targeted therapies, and assessing physiological functions. Their capacity to obtain internal health information while minimizing patient discomfort enhances their healthcare value. Ongoing improvements in miniature electronics, wireless connectivity, and biocompatible materials are expanding clinical use.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate as smart pills and ingestible sensors allow monitoring and diagnostic activities to take place within residential environments. These devices can support medication adherence, collect physiological information, and enable remote patient assessment, potentially limiting the need for repeated healthcare facility visits. Rising demand for convenient and personalized care is promoting connected medical technology adoption at home. Furthermore, integration with telemedicine services and remote monitoring platforms is increasing the relevance of ingestible technologies for home-based treatment, continuous observation, and long-term healthcare management.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by sophisticated healthcare systems, strong acceptance of advanced medical technologies, and a mature digital healthcare environment. The region has broad applications for connected medical devices, minimally invasive diagnostics, and remote patient monitoring. A well-developed network of healthcare providers, research institutions, and technology companies also contributes to market advancement. Growing healthcare digitalization and increasing emphasis on personalized treatment are further supporting the adoption of smart pills and ingestible sensor technologies across clinical settings.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, supported by increasing adoption of innovative healthcare monitoring and diagnostic solutions. Improvements in medical infrastructure, rising awareness of healthcare technologies, and growing preference for minimally invasive procedures are contributing to regional adoption. Healthcare digitalization and expanding remote monitoring practices are further strengthening opportunities for ingestible devices. In addition, advancing research capabilities, technological progress, and increased investment in healthcare are facilitating greater integration of smart pills and ingestible sensors across emerging medical applications.

Key players in the market

Some of the key players in Smart Pills & Ingestible Sensors Market include Medtronic, Olympus Corporation, CapsoVision, Inc., IntroMedic Co., Ltd., Check-Cap Ltd., ANX Robotica, BodyCap, etectRx, Otsuka Holdings, Proteus Digital Health, JINSHAN Science & Technology (Group) Co., Ltd., RF Co., Ltd., Koninklijke Philips N.V., Biora Therapeutics, Inc., Rani Therapeutics, Veloce Corporation, Endiatx and Fujifilm Holdings Corporation.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In October 2025, Philips Healthcare and Getinge have formed a new commercial partnership in Europe to offer customers easier access to a complete anesthesia and monitoring solution. By combining Philips' monitoring solutions with Getinge's leading anesthesia care products, the partnership provides a single point of contact for purchasing and support, helping clinicians deliver high-quality care in the operating room.

Product Types Covered:

Smart Pills
Ingestible Sensors

Sensor Types Covered:

Temperature Sensors
pH Sensors
Pressure Sensors
Image Sensors
Biosensors

Targeted Diseases Covered:

Gastrointestinal Disorders
Oncology
Neurological Disorders
Cardiovascular Disorders
Other Chronic Diseases

Applications Covered:

Patient Monitoring
Drug Delivery
Imaging & Diagnostics
Capsule Endoscopy

End Users Covered:

Hospitals & Clinics
Research Institutes
Home Healthcare

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Smart Pills & Ingestible Sensors Market, By Product Type

5.1 Smart Pills
5.2 Ingestible Sensors

6 Global Smart Pills & Ingestible Sensors Market, By Sensor Type

6.1 Temperature Sensors
6.2 pH Sensors
6.3 Pressure Sensors
6.4 Image Sensors
6.5 Biosensors

7 Global Smart Pills & Ingestible Sensors Market, By Targeted Disease

7.1 Gastrointestinal Disorders
7.2 Oncology
7.3 Neurological Disorders
7.4 Cardiovascular Disorders
7.5 Other Chronic Diseases

8 Global Smart Pills & Ingestible Sensors Market, By Application

8.1 Patient Monitoring
8.2 Drug Delivery
8.3 Imaging & Diagnostics
8.4 Capsule Endoscopy

9 Global Smart Pills & Ingestible Sensors Market, By End User

9.1 Hospitals & Clinics
9.2 Research Institutes
9.3 Home Healthcare

10 Global Smart Pills & Ingestible Sensors Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Medtronic
13.2 Olympus Corporation
13.3 CapsoVision, Inc.
13.4 IntroMedic Co., Ltd.
13.5 Check-Cap Ltd.
13.6 ANX Robotica
13.7 BodyCap
13.8 etectRx
13.9 Otsuka Holdings
13.10 Proteus Digital Health
13.11 JINSHAN Science & Technology (Group) Co., Ltd.
13.12 RF Co., Ltd.
13.13 Koninklijke Philips N.V.
13.14 Biora Therapeutics, Inc.
13.15 Rani Therapeutics
13.16 Veloce Corporation
13.17 Endiatx
13.18 Fujifilm Holdings Corporation

簡介目錄圖表

List of Tables

Table 1 Global Smart Pills & Ingestible Sensors Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Smart Pills & Ingestible Sensors Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Smart Pills & Ingestible Sensors Market Outlook, By Smart Pills (2023-2034) ($MN)
Table 4 Global Smart Pills & Ingestible Sensors Market Outlook, By Ingestible Sensors (2023-2034) ($MN)
Table 5 Global Smart Pills & Ingestible Sensors Market Outlook, By Sensor Type (2023-2034) ($MN)
Table 6 Global Smart Pills & Ingestible Sensors Market Outlook, By Temperature Sensors (2023-2034) ($MN)
Table 7 Global Smart Pills & Ingestible Sensors Market Outlook, By pH Sensors (2023-2034) ($MN)
Table 8 Global Smart Pills & Ingestible Sensors Market Outlook, By Pressure Sensors (2023-2034) ($MN)
Table 9 Global Smart Pills & Ingestible Sensors Market Outlook, By Image Sensors (2023-2034) ($MN)
Table 10 Global Smart Pills & Ingestible Sensors Market Outlook, By Biosensors (2023-2034) ($MN)
Table 11 Global Smart Pills & Ingestible Sensors Market Outlook, By Targeted Disease (2023-2034) ($MN)
Table 12 Global Smart Pills & Ingestible Sensors Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
Table 13 Global Smart Pills & Ingestible Sensors Market Outlook, By Oncology (2023-2034) ($MN)
Table 14 Global Smart Pills & Ingestible Sensors Market Outlook, By Neurological Disorders (2023-2034) ($MN)
Table 15 Global Smart Pills & Ingestible Sensors Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
Table 16 Global Smart Pills & Ingestible Sensors Market Outlook, By Other Chronic Diseases (2023-2034) ($MN)
Table 17 Global Smart Pills & Ingestible Sensors Market Outlook, By Application (2023-2034) ($MN)
Table 18 Global Smart Pills & Ingestible Sensors Market Outlook, By Patient Monitoring (2023-2034) ($MN)
Table 19 Global Smart Pills & Ingestible Sensors Market Outlook, By Drug Delivery (2023-2034) ($MN)
Table 20 Global Smart Pills & Ingestible Sensors Market Outlook, By Imaging & Diagnostics (2023-2034) ($MN)
Table 21 Global Smart Pills & Ingestible Sensors Market Outlook, By Capsule Endoscopy (2023-2034) ($MN)
Table 22 Global Smart Pills & Ingestible Sensors Market Outlook, By End User (2023-2034) ($MN)
Table 23 Global Smart Pills & Ingestible Sensors Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
Table 24 Global Smart Pills & Ingestible Sensors Market Outlook, By Research Institutes (2023-2034) ($MN)
Table 25 Global Smart Pills & Ingestible Sensors Market Outlook, By Home Healthcare (2023-2034) ($MN)